Le Lézard
Classified in: Health
Subject: SVY

Beta-glucan Market Analysis 2014-2017 & 2025: Increased Applications in Nutraceutical, Functional Food and Pharmaceutical Industries


DUBLIN, Jan. 23, 2018 /PRNewswire/ --

The "Beta-glucan Market Analysis By Source (Cereal, Mushroom, Yeasts, Seaweed), By Application (F&B, Personal Care, Pharmaceuticals, Animal Feed), By Type, By Region, And Segment Forecasts, 2014 - 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global beta-glucan market is expected to reach USD 727.2 million by 2025

The industry is anticipated to grow, primarily on account of its increased application in industries, including nutraceutical, functional food and pharmaceutical.

The consumers in the industry lay high emphasis on the source of the product. In addition, the overall quality is generally determined by the consumers through the certifications associated with the product. The industry is characterized by the presence of a notable regulatory framework with regulations related to processing, packaging, and transportation of the product.

Manufacturers are inclined toward use of innovative extraction methods such as AME, dry fractionation to increase the concentration of bioactive ingredients in the extract in an attempt to increase the customer base. Rising number of groceries, retail stores, and supermarkets offering the products are expected to trigger the industry growth.

There is an upsurge in the usage of seaweed for the extraction process with heavy investment noted by the companies which is anticipated to drive the industry growth over the forecast period. Mushroom is known to have more than 30 varieties, and is available in abundance across the globe, thereby benefitting the industry.

Further Key Findings From the Report Suggest:



Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary
2.1. Market Snapshot

Chapter 3. Beta-glucan Market Variables, Trends & Scope
3.1. Market segmentation
3.2. Market size and growth prospects, 2014 - 2025
3.3. Value chain analysis
3.4. Raw material analysis
3.5. Market dynamics
3.6. Key opportunities prioritized
3.7. Industry analysis - Porter's
3.8. PESTEL analysis, 2016

Chapter 4. Beta-glucan Market: Source Estimates & Trend Analysis
4.1. Beta-glucan market: Source movement analysis, 2016 & 2025
4.2. Cereal
4.3. Mushroom
4.4. Yeast
4.5. Seawood

Chapter 5. Beta-glucan Market: Type Estimates & Trend Analysis
5.1. Beta-glucan market: Type movement analysis, 2016 & 2025
5.2. Soluble
5.3. Insoluble

Chapter 6. Beta-glucan Market: Application Estimates & Trend Analysis
6.1. Beta-glucan market: Application movement analysis, 2016 & 2025
6.2. Food & Beverages
6.3. Cosmetics & Personal Care
6.4. Pharmaceutical
6.5. Animal Feed
6.6. Others

Chapter 7. Beta-glucan Market: Regional Estimates & Trend Analysis

Chapter 8 Competitive Landscape
8.1 Competitive Scenario
8.2 Vendor Landscape
8.3 Competitive Environment
8.4 Competitive Market Positioning
8.5 Heat Map Analysis
8.6 Market participation categorization

Chapter 9 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/p23f6f/betaglucan?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 




These press releases may also interest you

at 06:08
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...



News published on and distributed by: